Abbonarsi

Modified Zhizhu Pill improves the loperamide-induced slow transit constipation via gut microbiota and neurotransmitters in microbiota-gut-brain axis - 10/07/24

Doi : 10.1016/j.clinre.2024.102410 
Xu-Long Shen a, 1, Xiao-Ting Zhou b, 1, Min Ren c, Xin Shi d, Hai-Zhen Zhang e, Yu Wang a, Min Yang b,
a Anorectal Department, Luzhou People's Hospital, Luzhou, 646099, China 
b Department of Psychiatry, Luzhou Mental Hospital, Luzhou, 646000, China 
c Ophthalmology Department, Luzhou People's Hospital, Luzhou, 646099, China 
d General surgery Department, Luzhou People's Hospital, Luzhou, 646099, China 
e Oncology Department, Luzhou People's Hospital, Luzhou, 646099, China 

Corresponding author at: Department of Psychiatry, Luzhou Mental Hospital, No.10, Wanshun Road, Jiangyang District, Luzhou City, Sichuan Province, 646000, China.Department of PsychiatryLuzhou Mental HospitalNo.10, Wanshun Road, Jiangyang DistrictLuzhou CitySichuan Province646000China

Highlights

Modified Zhizhu Pill had a mitigating effect on loperamide-induced constipation in rats.
Modified Zhizhu Pill ameliorated the microecological dysbiosis of the intestinal microbiota.
Modified Zhizhu Pill improved neurotransmitters.
Modified Zhizhu Pill involved in microbiota-gut-brain axis.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background

Slow-transmission constipation is a type of intractable constipation with unknown etiology and unclear pathogenesis.

Objective

The intention of this study was to evaluate the therapeutic effect and possible mechanism of Modified Zhizhu Pills on loperamide-induced slow transit constipation.

Methods

The effects of the Modified Zhizhu Pill were evaluated in a rat model of constipation induced by subcutaneous administration of loperamide. Fecal parameters (fecal count, fecal water content, and fecal hardness) were measured in constipated rats. The substance, target, and pathway basis of the Modified Zhizhu Pill on constipation was investigated using network pharmacology. The microflora in rats was determined. Serum neurotransmitters (acetylcholine and 5-hydroxytryptamine) were measured in rats and their relationship with the gut microbiota was assessed.

Results

Modified Zhizhu Pill increased the number of bowel movements and fecal water content, and decreased fecal hardness and transit time. Network pharmacological analysis showed that Modified Zhizhu Pill can target multiple constipation-related targets and pathways through multiple potential active ingredients. Modified Zhizhu Pill alleviated loperamide-induced microbiota dysbiosis. Modified Zhizhu Pill increased serum 5-hydroxytryptamine and acetylcholine. The increase in serum 5-hydroxytryptamine and acetylcholine was associated with rat gut microbiota.

Conclusion

These results suggest that Modified Zhizhu Pill may increase intestinal motility and ultimately relieve constipation by improving microecological dysbiosis and neurotransmission.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Constipation, Herbal formula, Gut microbiota, Acetylcholine, 5-hydroxytryptamine


Mappa


© 2024  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 48 - N° 7

Articolo 102410- Agosto 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • HSP70 protects against acute pancreatitis-elicited intestinal barrier damage in rats
  • Sijin Chen, Rong Qin, Zhibo Zhang, Xirui Fan, Lifang Zhou, Hui Wang
| Articolo seguente Articolo seguente
  • Selective inner muscle layer myotomy is associated with lower pain and same clinical efficacy that full-thickness myotomy in patients treated by POEM for achalasia: A multicenter retrospective comparative analysis of 158 patients
  • Mathilde Sanavio, Blandine Vauquelin, Marie-Christine Picot, Romain Altwegg, Anne Bozon, Flora Charpy, Ludovic Caillo, Arthur Berger, Frank Zerbib, Antoine Debourdeau

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.